Aion Therapeutic Inc. (ANTCF)
Aion Therapeutic Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2.1M. On trailing twelve-month figures it carries a trailing P/E of -0.21, a net margin of -1710.9%. Its beta of 4.71 implies it has historically moved more than the broad market.
Aion Therapeutic Inc. operates within Canada, focusing on the provision of medicinal cannabis products. The company, which commenced operations in 2011, adopted its current name, Aion Therapeutic Inc., in August 2020, having previously been known as Osoyoos Cannabis Inc. Its main administrative base is located in Toronto, Canada.
Aion Therapeutic Inc. is most often compared with the following Healthcare names: